Contineum Therapeutics (CTNM) Tax Provisions (2023)
Historic Tax Provisions for Contineum Therapeutics (CTNM) over the last 1 years, with Q4 2023 value amounting to -$161000.0.
- Contineum Therapeutics' Tax Provisions changed N/A to -$161000.0 in Q4 2023 from the same period last year, while for Sep 2024 it was -$161000.0, marking a year-over-year change of. This contributed to the annual value of $450000.0 for FY2023, which is N/A changed from last year.
- As of Q4 2023, Contineum Therapeutics' Tax Provisions stood at -$161000.0.
- Contineum Therapeutics' 5-year Tax Provisions high stood at $729000.0 for Q2 2023, and its period low was -$161000.0 during Q4 2023.